Zhang Renfang, Gao Xiaohui, Gu Xinyu
Zhejiang University School of Medicine, Hangzhou, Zhejiang 310003, China.
Department of Oncology, The First Affiliated Hospital of Henan University of Science and Technology, Luoyang 471000, Henan, China.
Pathol Res Pract. 2023 Oct;250:154810. doi: 10.1016/j.prp.2023.154810. Epub 2023 Sep 9.
Long non-coding RNAs (lncRNAs) are transcripts that contain more than 200 nucleotides. Despite the fact that they cannot encode proteins, many studies have identified roles they play in human cancers through diverse mechanisms. BBOX1-AS1, an oncogenic lncRNA, has recently been demonstrated to participate in tumorigenesis and progression of numerous cancers. Experimental evidence has determined that it participates in diverse biological process, including cell proliferation, invasion, migration, and apoptosis. The dysregulation of BBOX1-AS1 exerts its oncogenicity by acting as a competitive endogenous RNA (ceRNA) or by directly impacting downstream molecules and signaling pathways. Here we summarize the current understanding of the biological functions and clinical significance of BBOX1-AS1 for human cancers.
长链非编码RNA(lncRNAs)是包含超过200个核苷酸的转录本。尽管它们不能编码蛋白质,但许多研究已经通过多种机制确定了它们在人类癌症中所起的作用。BBOX1-AS1是一种致癌lncRNA,最近已被证明参与多种癌症的肿瘤发生和进展。实验证据表明它参与多种生物学过程,包括细胞增殖、侵袭、迁移和凋亡。BBOX1-AS1的失调通过作为竞争性内源性RNA(ceRNA)或直接影响下游分子和信号通路发挥其致癌性。在这里,我们总结了目前对BBOX1-AS1在人类癌症中的生物学功能和临床意义的理解。